YOUTUBE- Jed's story
You are here
Petition is open until January 11th- Link to Petition plus other relevant info....
Here is a direct link to the number 10 petition that Michele started.
Here is a direct link to the number 10 petition that Michele started.
BBC News regarding NICE appraisal of dasatinib and nilotinib- plus TV3 interview regarding tasigna
BBC News regarding NICE appraisal of dasatinib and nilotinib
http://news.bbc.co.uk/1/hi/england/london/8440877.stm
BBC News regarding NICE appraisal of dasatinib and nilotinib
http://news.bbc.co.uk/1/hi/england/london/8440877.stm
Journal of Clinical Oncology Editorial: CML Reversing the Chronic Phase
JOURNAL OF CLINICAL ONCOLOGY
EDITORIAL
Chronic Myeloid Leukemia: Reversing the Chronic Phase
John M. Goldman, Imperial College London, London, United Kingdom
JOURNAL OF CLINICAL ONCOLOGY
EDITORIAL
Chronic Myeloid Leukemia: Reversing the Chronic Phase
John M. Goldman, Imperial College London, London, United Kingdom
Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia
Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia
J Clin Oncol. 2009 Dec 14; Epub online ahead of print, JE Cortes , D Jones, S O'Brien, E Jabbour, F Ravandi, C Koller, G Borthakur, B Walker, W Zhao, J Shan, H Kantarjian
Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia
J Clin Oncol. 2009 Dec 14; Epub online ahead of print, JE Cortes , D Jones, S O'Brien, E Jabbour, F Ravandi, C Koller, G Borthakur, B Walker, W Zhao, J Shan, H Kantarjian
From Gleevec to Tasigna: Novartis' Switch Push Kicks Off With Front-Line CML
From Gleevec to Tasigna: Novartis' Switch Push Kicks Off With Front-Line CML Submission
The Pink Sheet Daily. 2009 Dec 9, J Merrill
From Gleevec to Tasigna: Novartis' Switch Push Kicks Off With Front-Line CML Submission
The Pink Sheet Daily. 2009 Dec 9, J Merrill
Nilotinib shows improved response in newly diagnosed CML
Crucial differences between cancer and normal stem cells
Interactive
ecancer blog
Crucial differences between cancer and normal stem cells
18/12/2009
Posted by Dr. Clare Sansom, freelance
Interactive
ecancer blog
Crucial differences between cancer and normal stem cells
18/12/2009
Posted by Dr. Clare Sansom, freelance
Best of ASH Abstracts 2009- compiled by Jan Geissler
This is a compilation of the best/most relevant abstract presented at ASH conference this year. It was written by my friend and CML colleague, Jan Geissler, Director of leukemie-online.de
This is a compilation of the best/most relevant abstract presented at ASH conference this year. It was written by my friend and CML colleague, Jan Geissler, Director of leukemie-online.de
Jan Geisslers overview of ASH 2009
American Society of Heamatology Conference, New Orleans, Dec. 2009.
American Society of Heamatology Conference, New Orleans, Dec. 2009.